Melanoma

Adjuvant Therapy for High-Risk Melanoma

Adjuvant Therapy for High-Risk Melanoma

Systemic adjuvant therapy targets melanoma micrometastases in patients who…

Expiration Date: 3/27/2017

Max Credits: 0

View Activity

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Melanoma is the deadliest form of skin cancer. Historically, treatment opt…

Expiration Date: 2/25/2017

Max Credits: 0

View Activity

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Melanoma is the deadliest form of skin cancer. Historically, treatment opt…

Expiration Date: 2/25/2017

Max Credits: 0

View Activity

Predictive Biomarkers for Immunotherapy: Where Are we?

Predictive Biomarkers for Immunotherapy: Where Are we?

The identification of a robust and reproducible biomarker, which can be us…

Expiration Date: 1/26/2018

Max Credits: 0

View Activity

Immunotherapy

Immunotherapy

This CME Activity assesses the clinical utility of available and emerging …

Expiration Date: 9/23/2016

Max Credits: 0

View Activity

Sequencing/Combining Targeted Therapy and Immunotherapy

Sequencing/Combining Targeted Therapy and Immunotherapy

This CME Activity evaluates strategies for combining and sequencing target…

Expiration Date: 9/23/2016

Max Credits: 0

View Activity

Oncolytic Immunotherapy and Combinations

Oncolytic Immunotherapy and Combinations

Dr. Andtbacka assesses the value of oncolytic immunotherapy alone and in c…

Expiration Date: 9/23/2016

Max Credits: 0

View Activity

Metastatic Melanoma Management in Primary and Metastatic Melanoma

Metastatic Melanoma Management in Primary and Metastatic Melanoma

In this article, three different multidisciplinary panels of expert clinic…

Expiration Date: 10/10/2011

Max Credits: 0

View Activity